Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis

NCT07040332 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT07040332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07040332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis
Lead sponsor
Qianfoshan Hospital
Phase
Observational
Overall status
Recruiting
Start date
May 10, 2025
Completion date
January 31, 2029
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic bronchopulmonary aspergillosis (abpa)